Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

NCT07657312 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cytokine Release Syndrome
Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Infliximab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Talquetamab
DRUG: Teclistamab
PROCEDURE: X-Ray Imaging

Sponsor

Naresh Bumma

Collaborators

[object Object]
[object Object]